37 Pageviews Read Stories
Causes: Education, Special Education
Mission: The north american thrombosis forum (natf) is a nonprofit organization that focuses on unmet needs and issues related to thrombosis and cardiovascular diseases such as deep vein thrombosis, pulmonary embolism, myocardial infarction, peripheral arterial occlusive disease and stroke. The five areas of major focus are: 1) basic translational research, 2) clinical research, especially diagnosis and therapy, 3) prevention and education, 4) public policy and 5) advocacy. Natf's legacy will be to improve patient care, outcomes and public health by supporting thrombosis-related programs, such as novel research projects, innovative educational programs, public policy initiatives, regulatory issues and advocacy and to broaden training opportunities for physicians, scientists and other health professionals.
Programs: Education programs: natf planned and hosted a series of one to two day educational programs for healthcare providers across different specialties in the fields of thrombosis and cardiovascular medicine. Natf worked closely with thought leaders in the fields of cardiology, vascular medicine, heart failure, and hematology to put together these educational programs which were attended by physicians, nurses, pharmacists, and pas. All programs were held in boston, ma, but were attended by individuals throughout north america and as far away as brazil. Each attendee was also given a program syllabus which included all the presenters slides, speaker bios and contact information, as well as literature for additional reading. Thrombosis summit: this special two-day program provided a comprehensive review of the most important changes and advances impacting the care of patients who have, or are at risk for, thrombosis and cardiovascular disease. Updates in treatment, diagnosis, and prevention were given by leading experts in the fields of vascular medicine, cardiology, and hematology. This cme accredited program was for any healthcare provider involved in the care of patients with, or at risk for developing, thrombosis, cardiovascular disease, atrial fibrillation and stroke. We were fortunate to have 6 world renowned from the usa and canada faculty give state-of-the art lectures. There were 296 healthcare providers registered to attend this program. Each attendee was also given a program syllabus which included all the presenters slides, speaker bios and contact information, as well as literature for additional reading.